Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 15INDUSTRY 3NIH 2OTHER_GOV 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Head & Neck 3Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 550Head and Neck Neoplasms 490Carcinoma, Non-Small-Cell Lung 338Melanoma 217Colorectal Neoplasms 206Ovarian Neoplasms 174Neoplasms 171Breast Neoplasms 168Stomach Neoplasms 141Carcinoma, Renal Cell 133Uterine Cervical Neoplasms 129Neoplasm Metastasis 129Triple Negative Breast Neoplasms 125Lung Neoplasms 118Pancreatic Neoplasms 117Esophageal Neoplasms 107Thyroid Neoplasms 95Endometrial Neoplasms 93Urinary Bladder Neoplasms 92Prostatic Neoplasms 88Sarcoma 81Carcinoma, Squamous Cell 81Carcinoma, Transitional Cell 75Small Cell Lung Carcinoma 74Carcinoma, Hepatocellular 65Recurrence 53Nasopharyngeal Carcinoma 52Carcinoma 47Colonic Neoplasms 46Cholangiocarcinoma 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Leukoplakia × Head & Neck × Clear all
NCT04622462 2024-11-07

Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment

Proteocyte Diagnostics Inc.

Recruiting
500 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Disease, Erythroplasia, Hyperplasia, Leukoplakia, Mouth Neoplasms, Keratoderma, Palmoplantar, Epidermolytic

NCT05853783 2024-11-07

Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTEâ„¢

Proteocyte Diagnostics Inc.

Recruiting
180 enrolled
Head & Neck

Disease, Erythroplasia, Hyperplasia, Leukoplakia, Mouth Diseases, Keratoderma, Palmoplantar, Epidermolytic

NCT04148651 2022-03-22

The CO2RE® System for Vulvar Lichen Sclerosus

Candela Corporation

Phase NA Completed
14 enrolled 12 charts
GynecologicHead & Neck

Vulvar Lichen Sclerosus, Leukoplakia, Keratoderma, Palmoplantar, Epidermolytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡